HEART FAILURE REVIEWS

Scope & Guideline

Pioneering Discoveries in Heart Failure Therapies

Introduction

Welcome to your portal for understanding HEART FAILURE REVIEWS, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1382-4147
PublisherSPRINGER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1996 to 2024
AbbreviationHEART FAIL REV / Heart Fail. Rev.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS

Aims and Scopes

The journal "Heart Failure Reviews" aims to provide comprehensive insights into various aspects of heart failure, focusing on advancements in treatment, diagnosis, and management strategies. It encompasses a wide range of topics, including clinical studies, systematic reviews, and innovative therapies, making significant contributions to the field of cardiology.
  1. Clinical Management of Heart Failure:
    The journal emphasizes the importance of clinical management strategies for heart failure, including pharmacological treatments, lifestyle interventions, and the use of advanced therapies such as device management and surgical options.
  2. Innovative Therapeutic Approaches:
    Research published in the journal often explores novel therapeutic approaches, such as the use of SGLT2 inhibitors, GLP-1 receptor agonists, and other emerging drugs, highlighting their efficacy and mechanisms in heart failure management.
  3. Diagnosis and Prognosis:
    The journal focuses on advancements in diagnostic techniques, including echocardiography, cardiac MRI, and biomarkers, as well as prognostic tools that aid in assessing heart failure severity and outcomes.
  4. Pathophysiology and Mechanisms:
    A significant portion of the articles delve into the underlying mechanisms and pathophysiology of heart failure, including molecular, genetic, and inflammatory aspects that contribute to disease progression.
  5. Comorbidities and Multidisciplinary Care:
    The journal promotes the understanding of comorbid conditions associated with heart failure, advocating for a multidisciplinary approach to patient care that addresses both cardiac and non-cardiac issues.
The journal has shown an evolving focus on emerging trends and novel therapeutic approaches in heart failure management. Recent publications reflect a growing interest in integrating technology, personalized medicine, and innovative pharmacotherapies.
  1. Digital Health and Telemonitoring:
    The integration of digital health technologies and telemonitoring for heart failure management is increasingly highlighted, showcasing the potential for improving patient outcomes through remote monitoring and engagement.
  2. Heart Failure with Preserved Ejection Fraction (HFpEF):
    Research on HFpEF is gaining traction, with a focus on its unique challenges, therapeutic options, and the development of specific management guidelines, reflecting a better understanding of this complex condition.
  3. Personalized and Precision Medicine:
    There is a growing trend towards personalized medicine in heart failure treatment, with an emphasis on tailoring therapies based on genetic, molecular, and phenotypic characteristics of patients.
  4. Innovative Biomarkers and Diagnostic Tools:
    The exploration of novel biomarkers and advanced diagnostic tools, such as cardiac imaging techniques and machine learning algorithms, is becoming more prevalent, enhancing the ability to stratify risk and personalize treatment.
  5. Impact of Lifestyle Modifications:
    Recent publications increasingly emphasize the significance of lifestyle modifications, including dietary and exercise interventions, as integral components of heart failure management.

Declining or Waning

While the journal continues to thrive in many areas, certain themes appear to be losing prominence in recent publications. This may reflect shifts in research focus or advancements in treatment options that have rendered some topics less critical or outdated.
  1. Traditional Pharmacological Approaches:
    There seems to be a decreasing emphasis on traditional pharmacological treatments such as ACE inhibitors and beta-blockers, as newer therapies like SGLT2 inhibitors gain prominence in heart failure management.
  2. Isolated Studies on Specific Comorbidities:
    Research focusing solely on specific comorbidities without integrating them into a broader heart failure management context is becoming less frequent, indicating a shift towards more holistic approaches.
  3. Generalized Risk Factors:
    Articles that discuss generalized risk factors for heart failure without specific context or innovative approaches are appearing less often, as the field moves towards more targeted and individualized treatment strategies.

Similar Journals

Minerva Cardiology and Angiology

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: EDIZIONI MINERVA MEDICAISSN: 2724-5683Frequency: 6 issues/year

Minerva Cardiology and Angiology, published by EDIZIONI MINERVA MEDICA, is a prominent journal in the field of cardiology and cardiovascular medicine, with an ISSN of 2724-5683 and E-ISSN of 2724-5772. Established in 2021, this journal aims to foster the dissemination of cutting-edge research, clinical practice guidelines, and innovative methodologies relevant to cardiovascular health. As of 2023, it holds a commendable Q3 quartile rank in its category, reflecting its growing influence within the scientific community. The journal is indexed in Scopus, where it ranks #221 out of 387 in its field, placing it in the 43rd percentile overall. Although it currently does not offer Open Access options, articles published in Minerva Cardiology and Angiology contribute significantly to ongoing discussions and advancements in heart and vascular health. The journal serves as an invaluable resource for researchers, healthcare professionals, and students seeking to stay informed on the latest developments in cardiology.

ACTA CARDIOLOGICA

Advancing cardiovascular knowledge since 1946.
Publisher: TAYLOR & FRANCIS LTDISSN: 0001-5385Frequency: 6 issues/year

ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.

BASIC RESEARCH IN CARDIOLOGY

Driving innovation in cardiac research and clinical practice.
Publisher: SPRINGER HEIDELBERGISSN: 0300-8428Frequency: 6 issues/year

BASIC RESEARCH IN CARDIOLOGY, published by SPRINGER HEIDELBERG, is an esteemed peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine since 1973. With a strong emphasis on the latest breakthroughs in basic and translational research, this journal offers a platform for high-quality, impactful studies that contribute to our understanding of cardiac function and related physiological processes. Currently ranked in the Q1 category in Cardiology and Cardiovascular Medicine, as well as Physiology and Medical Physiology, BASIC RESEARCH IN CARDIOLOGY is recognized as a leading journal within these disciplines, boasting impressive Scopus ranks that place it in the top tiers of global research output. While it does not offer open access, its contributions are pivotal for researchers, clinicians, and students seeking to stay abreast of cutting-edge discoveries and methodologies in cardiovascular science. With its commitment to scholarly excellence, this journal plays a critical role in shaping the future of cardiac research and clinical practice.

Journal of Cardiovascular Echography

Advancing the frontiers of cardiovascular imaging.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2211-4122Frequency: 4 issues/year

Journal of Cardiovascular Echography, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, serves as a premier platform for global researchers, medical professionals, and students dedicated to the ever-evolving fields of cardiology and cardiovascular imaging. With the ISSN 2211-4122 and E-ISSN 2347-193X, this journal provides access to cutting-edge research from 2011 to 2024, offering insights into the latest advancements in echocardiographic techniques and their clinical applications. Despite its current classification in the Q3 quartile within both Cardiology and Cardiovascular Medicine as well as Radiology, Nuclear Medicine, and Imaging, it continues to make meaningful contributions to the academic community, ranking 234th in the Scopus category for Radiology and 278th in Cardiology. The Journal of Cardiovascular Echography is committed to furthering knowledge and fostering collaboration among researchers by sharing critical developments in the field, making it an essential resource for anyone looking to stay abreast of transformational changes in cardiovascular diagnostics.

HEART AND VESSELS

Transforming Heart Health Through Scholarly Excellence
Publisher: SPRINGERISSN: 0910-8327Frequency: 12 issues/year

HEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.

CARDIOLOGY CLINICS

Elevating the discourse on cardiovascular health worldwide.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0733-8651Frequency: 4 issues/year

CARDIOLOGY CLINICS is a prestigious journal published by W B SAUNDERS CO-ELSEVIER INC, offering insightful and comprehensive reviews in the field of cardiology and cardiovascular medicine since its inception in 1983. With its ISSN 0733-8651 and E-ISSN 1558-2264, the journal has established a significant impact factor within the academic community, holding a Q2 ranking in both Cardiology and Cardiovascular Medicine as well as in Medicine (miscellaneous) for 2023. Located in the heart of Philadelphia, USA, it serves as a vital resource for researchers, clinicians, and students seeking to deepen their understanding of cardiovascular diseases and advancements in treatment. Although it operates under a traditional subscription model, the journal remains committed to disseminating valuable knowledge that shapes current practices and informs future research directions. As it converges towards its 2024 issues, CARDIOLOGY CLINICS continues to play an influential role in enhancing the discourse on cardiovascular health worldwide, ensuring that its audience stays at the forefront of clinical and scientific developments.

International Heart Journal

Advancing Cardiovascular Knowledge Globally
Publisher: INT HEART JOURNAL ASSOCISSN: 1349-2365Frequency: 6 issues/year

International Heart Journal, published by INT HEART JOURNAL ASSOC, serves as a pivotal platform for research and discourse in the fields of cardiology and cardiovascular medicine. With its ISSN 1349-2365 and E-ISSN 1349-3299, this esteemed journal is based in Japan and is located at the University of Tokyo, Graduate School of Medicine, Department of Cardiovascular Medicine. Since its inception in 2005, International Heart Journal has blossomed into a respected publication with an impact factor that signifies its growing relevance, ranking in the Q3 category of both cardiology and miscellaneous medicine as of 2023. This journal not only disseminates vital research findings but also fosters collaboration among researchers and healthcare professionals. Notable for its Open Access options, it ensures the availability of its content to a broader audience, thereby enhancing knowledge transfer and innovation in cardiovascular care. With an ongoing commitment to improve clinical practice and patient outcomes, the journal continues to be an essential resource for those dedicated to advancing the understanding of heart health and disease.

Cardiac Failure Review

Transforming cardiovascular medicine through open access.
Publisher: RADCLIFFE CARDIOLOGYISSN: 2057-7540Frequency: 1 issue/year

Cardiac Failure Review, published by Radcliffe Cardiology, is a leading open-access journal dedicated to advancing the understanding and management of cardiac failure. With an ISSN of 2057-7540 and an E-ISSN of 2057-7559, this journal has gained significant recognition in the field, achieving a Q1 ranking in Cardiology and Cardiovascular Medicine as of 2023. Its impressive positioning at rank #97 out of 387 in Scopus further highlights its impact, placing it within the top 25th percentile of its category. Since transitioning to open access in 2019, Cardiac Failure Review has become increasingly accessible, ensuring that critical research findings are available to a global audience. The journal's focus spans innovative treatments, emerging technologies, and comprehensive reviews, effectively meeting the needs of researchers, clinicians, and students alike. With a commitment to excellence in cardiovascular medicine, Cardiac Failure Review plays a vital role in disseminating knowledge and fostering discussions that drive the field forward.

Cardiology Research and Practice

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: HINDAWI LTDISSN: 2090-8016Frequency: 1 issue/year

Cardiology Research and Practice is a leading academic journal dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by HINDAWI LTD, this journal has been an inclusive platform for open access research since 2009, facilitating the dissemination of high-quality studies that contribute to the global scientific community. With an impact factor placing it in Q2 of its category in 2023, it underscores its importance in delivering innovative insights and discoveries that shape clinical practices and policies. The journal covers a broad scope of topics including, but not limited to, cardiovascular disease prevention, innovative treatment modalities, and emerging technologies, appealing to researchers, healthcare professionals, and students alike. Located in the United States with its international reach, Cardiology Research and Practice serves as a critical resource for those dedicated to improving patient outcomes and advancing the field of cardiology.

Journal fur Kardiologie

Connecting Professionals with Essential Cardiology Insights.
Publisher: KRAUSE & PACHERNEGG GMBHISSN: 1024-0098Frequency: 12 issues/year

The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.